Inizio Engage has a long-standing partnership with a leading Biotechnology company, across Commercial, Patient Solutions and Medical Affairs businesses.
Inizio Engage has partnered with Eisai. We are seeking a performance-driven Pharmaceutical Field Sales Representative with a strong background in primary care and pharmaceutical sales. This role builds strategic territory business plans, understands customer needs, and drives sales performance for key neurology-focused targets.
This is your opportunity to join Inizio Engage and represent a top biopharmaceutical company!
What will you be doing? - Demonstrate deep marketplace, therapeutic, product and disease expertise based on a thorough understanding of scientific principles and clinical data, including mechanism of action, indications, efficacy, safety, etc.
- Understand and apply knowledge of the healthcare industry, market trends, regulations, and the neurology market access environment-including payer landscape, reimbursement processes, and patient pathways.
- Build and maintain strong professional relationships with physicians, HCPs, office staff, and other key stakeholders.
- Develop and execute territory business plans based on strategic analysis of market conditions and customer needs.
- Collaborate effectively with cross-functional teams to align on goals and deliver results.
Ask strategic, insightful questions to uncover customer needs and tailor solutions that improve the lives of patients.
What do you need for this position? - Bachelor's degree required
- 2+ years of pharmaceutical sales experience required
- Prior experience in Primary Care Provider (PCP) sales required
- Neurology experience a strong plus
- Proven track record of sales success
- Strong interpersonal communication and relationship-building skills
Resourceful, tech-savvy, and able to work with energetic independence
The base pay range for this position is $63K - $117K per year. The final compensation offered to a successful candidate will be determined by factors such as experience, skills, internal equity, and business needs.
